YCM
XERS icon

Yakira Capital Management’s Xeris Biopharma Holdings XERS Stock Holding History

Yakira Capital Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-34,538
Closed -$76.3K – 288
2024
Q1 		$76.3K Buy
+34,538
New +$89.4K 0.02% 138
2023
Q2 		– Sell
-90,076
Closed -$147K – 377
2023
Q1 		$147K Hold
90,076
– – 0.04% 159
2022
Q4 		$120K Hold
90,076
– – 0.02% 183
2022
Q3 		$141K Hold
90,076
– – 0.02% 251
2022
Q2 		$139K Sell
90,076
-27,000
-23% -$57K 0.02% 255
2022
Q1 		$300K Buy
+117,076
New +$286K 0.04% 271

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return

Yakira Capital Management's XERS Position: Q2 2024 in Review

Yakira Capital Management sold out of Xeris Biopharma Holdings (XERS) in Q2 2024, closing a stake of 34,538 shares — an estimated $76.3K sold.

Yakira Capital Management first reported a position in XERS in Q1 2022 and held it in 6 quarters. The position peaked at $300K in Q1 2022. 134 funds tracked by Wall St. Rank hold XERS as of Q2 2024.

  • Yakira Capital Management reported no remaining Xeris Biopharma Holdings position as of Q2 2024 after selling out during the quarter.
  • Yakira Capital Management sold 34,538 Xeris Biopharma Holdings shares in Q2 2024, an estimated $76.3K.
  • Yakira Capital Management first reported a position in Xeris Biopharma Holdings in Q1 2022 and held it in 6 quarters.
  • Yakira Capital Management's Xeris Biopharma Holdings position peaked at $300K in Q1 2022.
  • 134 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2024.

Based on Yakira Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.